SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Lifted by Private Advisor Group LLC

Private Advisor Group LLC boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 226,669 shares of the exchange traded fund’s stock after buying an additional 6,551 shares during the quarter. Private Advisor Group LLC owned 0.29% of SPDR S&P Biotech ETF worth $21,509,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. J.W. Cole Advisors Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 2.3% during the first quarter. J.W. Cole Advisors Inc. now owns 36,005 shares of the exchange traded fund’s stock valued at $3,417,000 after purchasing an additional 826 shares during the last quarter. Longbow Finance SA purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at $4,412,000. SpiderRock Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at $658,000. Arkadios Wealth Advisors lifted its holdings in shares of SPDR S&P Biotech ETF by 487.2% during the first quarter. Arkadios Wealth Advisors now owns 38,184 shares of the exchange traded fund’s stock valued at $3,623,000 after purchasing an additional 31,681 shares during the last quarter. Finally, Navis Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at $254,000.

SPDR S&P Biotech ETF Stock Up 0.9 %

Shares of NYSEARCA XBI traded up $0.84 during mid-day trading on Friday, hitting $91.71. 5,550,881 shares of the company traded hands, compared to its average volume of 10,581,949. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business has a 50 day moving average of $90.75 and a two-hundred day moving average of $90.99.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.